Evidence map›Paper›PMID 12773574›Full record

ArticleMolecular and cellular biology2003

Altered skeletal muscle phenotypes in calcineurin Aalpha and Abeta gene-targeted mice.

Stephanie A Parsons, Benjamin J Wilkins, Orlando F Bueno, Jeffery D Molkentin

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 156 citations in OpenAlex.

  1. Effects of mild-exercise training cessation in human skeletal muscle.European journal of applied physiology · 2012
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Calcineurin signaling in the heart: The importance of time and place.Journal of molecular and cellular cardiology · 2017
    Review
  12. Article
  13. The regulation of autophagy during exercise in skeletal muscle.Journal of applied physiology (Bethesda, Md. : 1985) · 2016
    Review
  14. Review
  15. Article
  16. Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Review
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Stephanie A ParsonsDepartment of Pediatrics, Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio 45229-3039, USA.
Benjamin J Wilkins
Orlando F Bueno
Jeffery D Molkentin
Children's Hospital & Medical Center · US

Funding

TRAINING IN CARDIOVASCULAR BIOLOGYT32HL007382 · NHLBI · UNIVERSITY OF CINCINNATI · PI SCHWARTZ, ARNOLD · 1985 to 2012
$5.9M
ROLE OF CALCINEURIN IN CARDIAC HYPERTROPHYF32HL010336 · NHLBI · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI BUENO, ORLANDO F · 2000 to 2002
$150k
NHLBI NIH HHS 5T32 HL07382NHLBI NIH HHS F32 HL010336NHLBI NIH HHS F32HL10336NHLBI NIH HHS T32 HL007382
6 · The paper itself

Abstract

Calcineurin is a calcium-regulated serine-threonine protein phosphatase that controls developmental and inducible biological responses in diverse cell types, in part through activation of the transcription factor nuclear factor of activated T cells (NFAT). In skeletal muscle, calcineurin has been implicated in the regulation of myoblast differentiation, hypertrophy of mature myofibers, and fiber type switching in response to alterations in intracellular calcium concentration. However, considerable disagreement persists about the functional role of calcineurin signaling in each of these processes. Here we evaluated the molecular phenotypes of skeletal muscle from both calcineurin Aalpha and calcineurin Abeta gene-targeted mice. Calcineurin Aalpha was observed to be the predominant catalytic isoform expressed in nearly all skeletal muscles examined. Neither calcineurin Aalpha or Abeta null mice showed any gross growth-related alterations in skeletal muscle, nor was fiber size or number altered in glycolytic/fast muscle types. In contrast, both calcineurin Aalpha and Abeta gene-targeted mice demonstrated an alteration in myofiber number in the soleus, an oxidative/slow-type muscle. More significantly, calcineurin Aalpha and Abeta gene-targeted mice showed a dramatic down-regulation in the oxidative/slow fiber type program in multiple muscles (both slow and fast). Associated with this observation, NFAT-luciferase reporter transgenic mice showed significantly greater activity in slow fiber-containing muscles than in fast. However, only calcineurin Aalpha null mice showed a defect in NFAT nuclear occupancy or NFAT-luciferase transgene activity in vivo. Collectively, our results suggest that calcineurin signaling plays a critical role in regulating skeletal muscle fiber type switching but not hypertrophy. Our results also suggest that fiber type switching occurs through an NFAT-independent mechanism.

Indexed as

AnimalsBlotting, WesternBrainCalcineurinCatalytic DomainCell NucleusDipeptidesDown-RegulationHypertrophyImmunohistochemistryMiceMice, TransgenicMuscle Fibers, Fast-TwitchMuscle Fibers, Slow-TwitchMuscle, SkeletalNADH Tetrazolium ReductaseCalcineurinDipeptidesN-(3-ethoxycarbonyloxirane-2-carbonyl)-isoleucyl-prolineNADH Tetrazolium ReductaseOxygenProtein Isoforms

Identifiers

PMID12773574
PMCPMC156151
OpenAlexW2135002082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.